Archive


Category: Update

  • Connecting Excipients with Drug Patents – New DrugPatentWatch module

    New DrugPatentWatch module connects excipients and drug patents In response to user requests, DrugPatentWatch has added a new database of excipients (inactive ingredients) in drugs, and integrated it with our… The post Connecting Excipients with Drug Patents – New DrugPatentWatch module appeared first on DrugPatentWatch – Make Better Decisions.

  • Say ‘NO’ to Bad Contracts

    Are you tired of having to navigate complicated contracts to access the information you need? Let DrugPatentWatch free you from weeks of negotiating complex contracts and let you focus on… The post Say ‘NO’ to Bad Contracts appeared first on DrugPatentWatch – Make Better Decisions.

  • DrugPatentWatch featured in Inc Magazine

    DrugPatentWatch was featured in a recent article by Inc. Magazine. In their coverage of Mark Cuban’s new pharma company, they cited our published interview where Mark Cuban Sounds off on Drug Prices.… The post DrugPatentWatch featured in Inc Magazine appeared first on DrugPatentWatch – Make Better Decisions.

  • Regenxbio Reports the Initiation of First Pivotal Program for RGX-314 to Treat Wet AMD

    Shots: Regenxbio has reported that the ATMOSPHERE trial evaluating RGX-314 is active and patient screening is ongoing. The study will enroll 300 patients across two RGX-314 dose arms vs ranibizumab, with anticipated initiation of patients dosing in Q1’21 The second trial is expected to be similar in design to ATMOSPHERE with its expected initiation in […]

  • Voyager Therapeutics Provides Update on NBIB-1817(VY-AADC) Program to Treat Parkinson Disease

    Shots: The P-ll RESTORE-1 study involves assessing NBIb-1817(VY-AADC) for the treatment of Parkinson’s disease. Neuroscience & Voyager will closely work with FDA & DCMB to determine the next clinical trial for RESTORE-1 DSMB request a clinical hold, follows the IND Safety Report submit by Neurocrine Biosciences related to the observation of MRI abnormalities in some […]

  • Essential Medicines and Patents

    Mark Schultz and Jaci McDole recently used DrugPatentWatch to complete a report on recent trends in the latest editions of the world health organization essential medicines list. Some of their key… The post Essential Medicines and Patents appeared first on DrugPatentWatch – Make Better Decisions.

  • Jounce Stops Enrollment in P-II EMERGE Study Evaluating Vopratelimab for Lung Cancer

    Shots: The company will not expand the P-II EMERGE study that assesses Vopratelimab + ipilimumab in PD-(L)1 inhibitor experienced NSCLC patient. Early evaluation of the study showed that the trial will not meet pre-specified interim criteria for continuation of enrollment The company also reported the first patient dosing in P-II SELECT study assessing Vopratelimab + […]

  • Finding and Evaluating Market Entry Opportunities for a Better ROI

    I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th Portfolio Management & Pipeline Optimization for Generics from September 30th… The post Finding and Evaluating Market Entry Opportunities for a Better ROI appeared first on DrugPatentWatch – Make Better Decisions.

  • DrugPatentWatch and Bloomberg: Are there too many generic patent challenges?

    Check out this Bloomberg Law article where DrugPatentWatch shows how the number of patent challenges is increasing, while the number of challengers of each patent is also increasing. Why might this… The post DrugPatentWatch and Bloomberg: Are there too many generic patent challenges? appeared first on DrugPatentWatch – Make Better Decisions.

  • Lab Manager Ask the Expert

    Check out the latest issue of Lab Manager where I discuss my interest in informatics, the complexities of informatics for today’s scientists, and some of the tools available. https://www.labmanager.com/ask-the-expert/trends-in-informatics-22895 The post Lab Manager Ask the Expert appeared first on DrugPatentWatch – Make Better Decisions.

  • DrugPatentWatch Headlines Swissbiotech Annual Report

    The latest Swiss Biotech annual report focuses on the theme of shaping change. Change is a theme DrugPatentWatch is very familiar with — whether it is a matter of tracking… The post DrugPatentWatch Headlines Swissbiotech Annual Report appeared first on DrugPatentWatch – Make Better Decisions.